Love and science
Jaime and Sylvia Liwerant’s love and legacy will be woven into countless studies at LJI.
No patient overlooked
LJI postdoctoral research Jermaine Khumalo, Ph.D., has a new strategy for studying asthma.
Fresh perspectives come from LJI scientists
Our Spring 2022 letter from President and CEO Erica Ollmann Saphire, Ph.D.
A small mutation can make Zika virus even more dangerous
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have found that Zika virus can mutate to become more
The sky, the sea, and Ebola virus
Jingru Fang shares how her Ph.D. research inspired a vivid painting
Targeting a human protein may stop Ebola virus in its tracks
LA JOLLA, CA—To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus:
Op-Ed: What will it take to make a universal COVID vaccine?
As California emerges from Omicron, other places are again in lockdown or facing record caseloads after trying and failing to
Scientists uncover new targets for treating Parkinson’s disease
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson’s disease have a clear
Promising antibody cocktail takes on Ebola virus—and its deadly cousin
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
Local students create eye-catching art for our second ‘Art of the Immune System’ competition
Winning artists drew inspiration from the pandemic and the power of vaccines
LJI team uncovers new subsets of CD4+ ‘helper’ T cells
New analysis shows men and women really do have immune cell differences